The prevalence of autosomal dominant polycystic kidney disease (ADPKD): A meta-analysis of European literature and prevalence evaluation in the Italian province of Modena suggest that ADPKD is a rare and underdiagnosed condition

PLoS ONE

Volumn 13, Issue 1, 2018, Pages

  Solazzo, Andrea ^a   Testa, Francesca ^a   Giovanella, Silvia ^a   Busutti, Marco ^b   Furci, Luciana ^c   Carrera, Paola ^d   Ferrari, Maurizio ^d,e   Ligabue, Giulia ^a   Mori, Giacomo ^c   Leonelli, Marco ^c   Cappelli, Gianni ^a,c   Magistroni, Riccardo ^a,c  

^a UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^b UNIVERSITY OF BOLOGNA   (Italy)

^c UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^d SAN RAFFAELE HOSPITAL   (Italy)

^e VITA SALUTE SAN RAFFAELE UNIVERSITY   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CLINICAL FEATURE; EPIDEMIOLOGICAL DATA; EUROPE; HIGH RISK POPULATION; HUMAN; INCIDENCE; ITALY; KIDNEY POLYCYSTIC DISEASE; MEDICAL LITERATURE; MEDICAL RESEARCH; PEDIGREE ANALYSIS; PREDICTION; PREVALENCE; SYSTEMATIC REVIEW; AGED; COHORT ANALYSIS; FEMALE; MALE; META ANALYSIS; MIDDLE AGED;

AGED; COHORT STUDIES; EUROPE; FEMALE; HUMANS; MALE; MIDDLE AGED; POLYCYSTIC KIDNEY, AUTOSOMAL DOMINANT; PREVALENCE;

EID: 85040616136     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0190430     Document Type: Article

References (44)

1. Pippias M, Kramer A, Noordzij M, Afentakis N, Alonso de la Torre R, Ambühl PM, et al. The European Renal Association–European Dialysis and Transplant Association Registry Annual Report 2014: a summary. Clinical Kidney Journal. 2017; 10(2):154–69. https://doi.org/10.1093/ckj/sfw135 PMID: 28584624
2. Spithoven EM, Kramer A, Meijer E, Orskov B, Wanner C, Caskey F, et al. Analysis of data from the ERA-EDTA Registry indicates that conventional treatments for chronic kidney disease do not reduce the need for renal replacement therapy in autosomal dominant polycystic kidney disease. Kidney Int. 2014; 86(6):1244–52. https://doi.org/10.1038/ki.2014.120 PMID: 24827775.
3. Grantham JJ. Clinical practice. Autosomal dominant polycystic kidney disease. N Engl J Med. 2008; 359(14):1477–85. https://doi.org/10.1056/NEJMcp0804458 PMID: 18832246.
4. Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007; 369 (9569):1287–301. Epub 2007/04/17. doi: S0140-6736(07)60601-1 [pii] https://doi.org/10.1016/S0140-6736(07)60601-1 PMID: 17434405.
5. Porath B, Gainullin VG, Cornec-Le Gall E, Dillinger EK, Heyer CM, Hopp K, et al. Mutations in GANAB, Encoding the Glucosidase IIalpha Subunit, Cause Autosomal-Dominant Polycystic Kidney and Liver Disease. Am J Hum Genet. 2016; 98(6):1193–207. https://doi.org/10.1016/j.ajhg.2016.05.004 PMID: 27259053.
6. Cabezas OR, Flanagan SE, Stanescu H, Garcia-Martinez E, Caswell R, Lango-Allen H, et al. Polycystic Kidney Disease with Hyperinsulinemic Hypoglycemia Caused by a Promoter Mutation in Phosphoman-nomutase 2. J Am Soc Nephrol. 2017. https://doi.org/10.1681/ASN.2016121312 PMID: 28373276.
7. Dalgaard OZ. Bilateral polycystic disease of the kidneys; a follow-up of two hundred and eighty-four patients and their families. Acta Med Scand Suppl. 1957; 328:1–255. PMID: 13469269.
8. Barua M, Cil O, Paterson AD, Wang K, He N, Dicks E, et al. Family history of renal disease severity predicts the mutated gene in ADPKD. J Am Soc Nephrol. 2009; 20(8):1833–8. https://doi.org/10.1681/ASN.2009020162 PMID: 19443633; PubMed Central PMCID: PMCPMC2723982.
9. Davies F, Coles GA, Harper PS, Williams AJ, Evans C, Cochlin D. Polycystic kidney disease re-evaluated: a population-based study. The Quarterly journal of medicine. 1991; 79(290):477–85. PMID: 1946928.
10. de Almeida E, Sousa A, Pires C, Aniceto J, Barros S, Prata MM. Prevalence of autosomal-dominant polycystic kidney disease in Alentejo, Portugal. Kidney Int. 2001; 59(6):2374. https://doi.org/10.1046/j.1523-1755.2001.00758.x PMID: 11380844.
11. Heidland A, Bahner U, Deetjen A, Gotz R, Heidbreder E, Schafer R, et al. Mass-screening for early detection of renal disease: benefits and limitations of self-testing for proteinuria. J Nephrol. 2009; 22 (2):249–54. PMID: 19384843.
12. Higashihara E, Nutahara K, Kojima M, Tamakoshi A, Yoshiyuki O, Sakai H, et al. Prevalence and renal prognosis of diagnosed autosomal dominant polycystic kidney disease in Japan. Nephron. 1998; 80 (4):421–7. PMID: 9832641.
13. Iglesias CG, Torres VE, Offord KP, Holley KE, Beard CM, Kurland LT. Epidemiology of adult polycystic kidney disease, Olmsted County, Minnesota: 1935–1980. Am J Kidney Dis. 1983; 2(6):630–9. PMID: 6846334.
14. McGovern AP, Jones S, van Vlymen J, Saggar AK, Sandford R, de Lusignan S. Identification of people with autosomal dominant polycystic kidney disease using routine data: a cross sectional study. BMC Nephrol. 2014; 15:182. https://doi.org/10.1186/1471-2369-15-182 PMID: 25412767; PubMed Central PMCID: PMCPMC4258046.
15. Neumann HP, Jilg C, Bacher J, Nabulsi Z, Malinoc A, Hummel B, et al. Epidemiology of autosomal-dominant polycystic kidney disease: an in-depth clinical study for south-western Germany. Nephrol Dial Transplant. 2013; 28(6):1472–87. https://doi.org/10.1093/ndt/gfs551 PMID: 23300259.
16. Patch C, Charlton J, Roderick PJ, Gulliford MC. Use of antihypertensive medications and mortality of patients with autosomal dominant polycystic kidney disease: a population-based study. Am J Kidney Dis. 2011; 57(6):856–62. https://doi.org/10.1053/j.ajkd.2011.01.023 PMID: 21458899.
17. Sandro Rossetti MA, Kubly Vickie, Consugar Mark B., Torres Vicente E., Harris Peter C. An Olmsted County Population-Based Study Indicates That PKD2 Is More Common Than Previously Described. J Am Soc Nephrol. 2007; 18:365A.
18. Simon P, Le Goff JY, Ang KS, Charasse C, Le Cacheux P, Cam G. [Epidemiologic data, clinical and prognostic features of autosomal dominant polycystic kidney disease in a French region]. Nephrologie. 1996; 17(2):123–30. PMID: 8838759.
19. Sweeney WE Jr., Avner ED. Pathophysiology of childhood polycystic kidney diseases: new insights into disease-specific therapy. Pediatr Res. 2014; 75(1–2):148–57. https://doi.org/10.1038/pr.2013.191PMID: 24336431; PubMed Central PMCID: PMCPMC3953890.
20. World MJ. Military nephrology: a review of cases 1985–2011. Journal of the Royal Army Medical Corps. 2012; 158(4):300–4. PMID: 23402065.
21. Yersin C, Bovet P, Wauters JP, Schorderet DF, Pescia G, Paccaud F. Frequency and impact of autosomal dominant polycystic kidney disease in the Seychelles (Indian Ocean). Nephrol Dial Transplant. 1997; 12(10):2069–74. PMID: 9351067.
22. Eijan J. EPIDEMIOLOGY OF AUTOSOMAL-DOMINANT POLYCYSTIC KIDNEY-DISEASE IN GALI-CIA—IMPACT OF RENAL REPLACEMENT THERAPY. Nefrologia. 1993; 13(2):122–6. PubMed PMID: WOS:A1993LC70500004.
23. Pei Y, Obaji J, Dupuis A, Paterson AD, Magistroni R, Dicks E, et al. Unified criteria for ultrasonographic diagnosis of ADPKD. J Am Soc Nephrol. 2009; 20(1):205–12. Epub 2008/10/24. doi: ASN.2008050507 [pii] https://doi.org/10.1681/ASN.2008050507 PMID: 18945943; PubMed Central PMCID: PMC2615723.
24. Pei Y, Hwang YH, Conklin J, Sundsbak JL, Heyer CM, Chan W, et al. Imaging-based diagnosis of autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2015; 26(3):746–53. https://doi.org/10.1681/ASN.2014030297 PMID: 25074509.
25. Richards S, Aziz N, Bale S, Bick D, Das S, Gastier-Foster J, et al. Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology. Genetics in medicine: official journal of the American College of Medical Genetics. 2015; 17(5):405–23. https://doi.org/10.1038/gim.2015.30 PMID: 25741868.
26. Higgins JP, Thompson SG, Deeks JJ, Altman DG. Measuring inconsistency in meta-analyses. BMJ. 2003; 327(7414):557–60. https://doi.org/10.1136/bmj.327.7414.557 PMID: 12958120; PubMed Central PMCID: PMCPMC192859.
27. Muller CJ, MacLehose RF. Estimating predicted probabilities from logistic regression: different methods correspond to different target populations. International journal of epidemiology. 2014; 43(3):962–70. https://doi.org/10.1093/ije/dyu029 PMID: 24603316; PubMed Central PMCID: PMC4052139.
28. Hwang YH, Conklin J, Chan W, Roslin NM, Liu J, He N, et al. Refining Genotype-Phenotype Correlation in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015. https://doi.org/10.1681/ASN.2015060648 PMID: 26453610.
29. Cornec-Le Gall E, Audrezet MP, Chen JM, Hourmant M, Morin MP, Perrichot R, et al. Type of PKD1 mutation influences renal outcome in ADPKD. J Am Soc Nephrol. 2013; 24(6):1006–13. Epub 2013/02/ 23. https://doi.org/10.1681/ASN.2012070650 ASN.2012070650 [pii]. PMID: 23431072; PubMed Central PMCID: PMC3665389.
30. Cornec-Le Gall E, Audrezet MP, Rousseau A, Hourmant M, Renaudineau E, Charasse C, et al. The PROPKD Score: A New Algorithm to Predict Renal Survival in Autosomal Dominant Polycystic Kidney Disease. J Am Soc Nephrol. 2015. https://doi.org/10.1681/ASN.2015010016 PMID: 26150605.
31. Carrera P, Calzavara S, Magistroni R, den Dunnen JT, Rigo F, Stenirri S, et al. Deciphering Variability of PKD1 and PKD2 in an Italian Cohort of 643 Patients with Autosomal Dominant Polycystic Kidney Disease (ADPKD). Sci Rep. 2016; 6:30850. https://doi.org/10.1038/srep30850 PMID: 27499327.
32. Fokkema IF, den Dunnen JT, Taschner PE. LOVD: easy creation of a locus-specific sequence variation database using an "LSDB-in-a-box" approach. Hum Mutat. 2005; 26(2):63–8. Epub 2005/06/25. https://doi.org/10.1002/humu.20201 PMID: 15977173.
33. Fokkema IF, Taschner PE, Schaafsma GC, Celli J, Laros JF, den Dunnen JT. LOVD v.2.0: the next generation in gene variant databases. Hum Mutat. 2011; 32(5):557–63. https://doi.org/10.1002/humu. 21438 PMID: 21520333.
34. Moher D, Liberati A, Tetzlaff J, Altman DG, The PG. Preferred Reporting Items for Systematic Reviews and Meta-Analyses: The PRISMA Statement. PLOS Medicine. 2009; 6(7):e1000097. https://doi.org/10.1371/journal.pmed.1000097 PMID: 19621072
35. Corradi V, Gastaldon F, Virzi GM, Clementi M, Nalesso F, Cruz DN, et al. [Epidemiological and molecular study of autosomal dominant polycystic kidney disease (ADPKD) in the province of Vicenza, Italy: possible founder effect?]. G Ital Nefrol. 2010; 27(6):655–63. PMID: 21132648.
36. Irazabal MV, Rangel LJ, Bergstralh EJ, Osborn SL, Harmon AJ, Sundsbak JL, et al. Imaging Classification of Autosomal Dominant Polycystic Kidney Disease: A Simple Model for Selecting Patients for Clinical Trials. J Am Soc Nephrol. 2014. https://doi.org/10.1681/ASN.2013101138 PMID: 24904092.
37. Willey CJ, Blais JD, Hall AK, Krasa HB, Makin AJ, Czerwiec FS. Prevalence of autosomal dominant polycystic kidney disease in the European Union. Nephrol Dial Transplant. 2016;gfw240. https://doi.org/10.1093/ndt/gfw240 PMID: 27325254.
38. Gansevoort RT, Arici M, Benzing T, Birn H, Capasso G, Covic A, et al. Recommendations for the use of tolvaptan in autosomal dominant polycystic kidney disease: a position statement on behalf of the ERA-EDTA Working Groups on Inherited Kidney Disorders and European Renal Best Practice. Nephrology Dialysis Transplantation. 2016:gfv456. https://doi.org/10.1093/ndt/gfv456 PMID: 26908832
39. Iliuta IA, Kalatharan V, Wang K, Cornec-Le Gall E, Conklin J, Pourafkari M, et al. Polycystic Kidney Disease without an Apparent Family History. J Am Soc Nephrol. 2017; 28(9):2768–76. https://doi.org/10.1681/ASN.2016090938 PMID: 28522688; PubMed Central PMCID: PMCPMC5576926.
40. Schrier RW, Abebe KZ, Perrone RD, Torres VE, Braun WE, Steinman TI, et al. Blood pressure in early autosomal dominant polycystic kidney disease. N Engl J Med. 2014; 371(24):2255–66. https://doi.org/10.1056/NEJMoa1402685 PMID: 25399733; PubMed Central PMCID: PMC4343258.
41. Torres VE, Abebe KZ, Chapman AB, Schrier RW, Braun WE, Steinman TI, et al. Angiotensin blockade in late autosomal dominant polycystic kidney disease. N Engl J Med. 2014; 371(24):2267–76. https://doi.org/10.1056/NEJMoa1402686 PMID: 25399731; PubMed Central PMCID: PMC4284824.
42. Ecder T. Cardiovascular complications in autosomal dominant polycystic kidney disease. Curr Hyper-tens Rev. 2013; 9(1):2–11. PMID: 23971638.
43. Schrier RW. Hypertension and autosomal dominant polycystic kidney disease. Am J Kidney Dis. 2011; 57(6):811–3. https://doi.org/10.1053/j.ajkd.2011.02.379 PMID: 21601126.
44. Schrier RW, Johnson AM, McFann K, Chapman AB. The role of parental hypertension in the frequency and age of diagnosis of hypertension in offspring with autosomal-dominant polycystic kidney disease. Kidney Int. 2003; 64(5):1792–9. https://doi.org/10.1046/j.1523-1755.2003.00264.x PMID: 14531813.